Dataset Information


Consumption of NADPH for 2-HG Synthesis Increases Pentose Phosphate Pathway Flux and Sensitizes Cells to Oxidative Stress.

ABSTRACT: Gain-of-function mutations in isocitrate dehydrogenase 1 (IDH1) occur in multiple types of human cancer. Here, we show that these mutations significantly disrupt NADPH homeostasis by consuming NADPH for 2-hydroxyglutarate (2-HG) synthesis. Cells respond to 2-HG synthesis, but not exogenous administration of 2-HG, by increasing pentose phosphate pathway (PPP) flux. We show that 2-HG production competes with reductive biosynthesis and the buffering of oxidative stress, processes that also require NADPH. IDH1 mutants have a decreased capacity to synthesize palmitate and an increased sensitivity to oxidative stress. Our results demonstrate that, even when NADPH is limiting, IDH1 mutants continue to synthesize 2-HG at the expense of other NADPH-requiring pathways that are essential for cell viability. Thus, rather than attempting to decrease 2-HG synthesis in the clinic, the consumption of NADPH by mutant IDH1 may be exploited as a metabolic weakness that sensitizes tumor cells to ionizing radiation, a commonly used anti-cancer therapy.


PROVIDER: S-EPMC6053654 | BioStudies | 2018-01-01

REPOSITORIES: biostudies

Similar Datasets

2016-01-01 | S-EPMC4962051 | BioStudies
2010-01-01 | S-EPMC2822606 | BioStudies
1000-01-01 | S-EPMC4494954 | BioStudies
1000-01-01 | S-EPMC5651864 | BioStudies
2014-01-01 | S-EPMC4022846 | BioStudies
2019-01-01 | S-EPMC6526618 | BioStudies
2014-01-01 | S-EPMC3946987 | BioStudies
2019-01-01 | S-EPMC6966450 | BioStudies
2012-01-01 | S-EPMC3340216 | BioStudies
2011-01-01 | S-EPMC3229304 | BioStudies